$LGYV
LEGACY VENTURES INTERNATIONAL INC.

2023 Q4 Form 10-Q Financial Statement

#000149315223039448 Filed on November 06, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.77K $6.740K $9.670K
YoY Change -35.85% -30.3% 5.57%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $10.77K $6.740K $9.670K
YoY Change -35.85% -30.3% 5.57%
Operating Profit -$10.77K -$6.744K -$9.667K
YoY Change -35.87% -30.24% 5.53%
Interest Expense $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net -$146.00
YoY Change -100.05%
Pretax Income -$10.77K -$6.744K -$9.813K
YoY Change -35.89% -31.27% -103.73%
Income Tax
% Of Pretax Income
Net Earnings -$10.77K -$6.744K -$9.813K
YoY Change -35.89% -31.27% -103.73%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 -$195.00
COMMON SHARES
Basic Shares Outstanding 50.32M shares 50.32M shares 50.32M shares
Diluted Shares Outstanding 50.32M shares 50.32M shares 50.32M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $840.00 $840.00 $4.460K
YoY Change 133.33% -81.17%
Cash & Equivalents $842.00 $842.00 $4.456K
Short-Term Investments
Other Short-Term Assets $510.00 $510.00
YoY Change 0.0%
Inventory
Prepaid Expenses $509.00 $509.00
Receivables
Other Receivables
Total Short-Term Assets $1.350K $1.350K $4.460K
YoY Change 55.17% -69.73%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.00 $1.00 -$4.00
YoY Change -120.0% -125.0%
TOTAL ASSETS
Total Short-Term Assets $1.350K $1.350K $4.460K
Total Long-Term Assets $1.00 $1.00 -$4.00
Total Assets $1.351K $1.351K $4.456K
YoY Change 56.18% -69.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.03K $35.51K $13.50K
YoY Change 14.91% 163.04% -85.81%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $91.45K $80.68K $24.97K
YoY Change 139.52% 223.11% -73.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $91.45K $80.68K $24.97K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $91.45K $80.68K $24.97K
YoY Change 139.53% 223.06% -73.75%
SHAREHOLDERS EQUITY
Retained Earnings -$6.525M -$6.514M -$6.455M
YoY Change 0.82% 0.91%
Common Stock $5.032K $5.032K $5.032K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$90.10K -$79.33K -$20.52K
YoY Change
Total Liabilities & Shareholders Equity $1.351K $1.351K $4.456K
YoY Change 56.18% -69.68%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$10.77K -$6.744K -$9.813K
YoY Change -35.89% -31.27% -103.73%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$32.24K -$9.836K -$16.56K
YoY Change 686.34% -40.61% -73.62%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 32.25K $9.000K
YoY Change
NET CHANGE
Cash From Operating Activities -32.24K -$9.836K -$16.56K
Cash From Investing Activities
Cash From Financing Activities 32.25K $9.000K
Net Change In Cash 10.00 -$836.00 -$16.56K
YoY Change -100.24% -94.95% -27.3%
FREE CASH FLOW
Cash From Operating Activities -$32.24K -$9.836K -$16.56K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001616788
CY2023Q3 LGYV Bank Charges And Other
BankChargesAndOther
usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2022Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
000-55849
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
LEGACY VENTURES INTERNATIONAL, INC
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-0826318
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
Unit 01, 82/F. International Commerce Centre
CY2023Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
1 Austin Road West
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Kowloon
CY2023Q3 dei Entity Address Country
EntityAddressCountry
HK
CY2023Q3 dei City Area Code
CityAreaCode
+852
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
3960 6394
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50315064 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
842 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1678 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
509 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
509 usd
CY2023Q3 us-gaap Assets
Assets
1351 usd
CY2023Q2 us-gaap Assets
Assets
2187 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
35510 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
38602 usd
CY2023Q3 us-gaap Liabilities
Liabilities
80678 usd
CY2023Q2 us-gaap Liabilities
Liabilities
74770 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50315064 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50315064 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50315064 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50315064 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
5032 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
5032 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6429771 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6429771 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6514130 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6507386 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-79327 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-72583 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1351 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2187 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
5500 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
8296 usd
CY2023Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1244 usd
CY2022Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1371 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6744 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9667 usd
CY2022Q3 LGYV Bank Charges And Other
BankChargesAndOther
-146 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-146 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6744 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9813 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6744 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9813 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50315064 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50315064 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50315064 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50315064 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-10704 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9813 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-20517 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-72583 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-72583 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6744 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-79327 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-79327 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6744 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9813 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3092 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6748 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9836 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16561 usd
CY2023Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
9000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-836 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-16561 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1678 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21017 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
842 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4456 usd
CY2023Q3 LGYV Working Capital Deficit
WorkingCapitalDeficit
79327 usd
CY2023Q2 LGYV Working Capital Deficit
WorkingCapitalDeficit
72583 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6514130 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6507386 usd
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50315064 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50315064 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50315064 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50315064 shares

Files In Submission

Name View Source Status
0001493152-23-039448-index-headers.html Edgar Link pending
0001493152-23-039448-index.html Edgar Link pending
0001493152-23-039448.txt Edgar Link pending
0001493152-23-039448-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
lgyv-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lgyv-20230930_def.xml Edgar Link unprocessable
lgyv-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
lgyv-20230930_lab.xml Edgar Link unprocessable
lgyv-20230930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed